Denghai Zhang
Impact in
-
- Natural Compounds in Disease Treatment
-
- Intensive Care Unit Cognitive Disorders
Papers in
-
- Natural Compounds in Disease Treatment 15
-
- Heat shock proteins research 2
- Cell death mechanisms and regulation 2
- Circular RNAs in diseases 2
- Co-authors
- Xue Zhang (10 shared papers)Bin Peng (1 shared paper)Yuting Song (3 shared papers)Georges Uzan (13 shared papers)Bin Peng (13 shared papers)Fanfan Cao (12 shared papers)Zhi‐Ru Ge (1 shared paper)Shengqiong Deng (1 shared paper)
- Journals
- Journal of Integrative Medicine (3 papers)Molecular Cancer (2 papers)International Immunopharmacology (2 papers)BMC Cancer (2 papers)PLoS ONE (2 papers)
- Partner nations
- ChinaFranceUnited States
In The Last Decade
Denghai Zhang
36 papers receiving 1.4k citations
Denghai Zhang's Hit Papers
Peers
Comparison fields: 5 of 105
- Complementary and alternative medicine 323
- Critical Care and Intensive Care Medicine 106
- Developmental Neuroscience 79
- Pharmacology 141
- Cancer Research 185
Countries citing papers authored by Denghai Zhang
This map shows the geographic impact of Denghai Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denghai Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denghai Zhang more than expected).
Fields of papers citing papers by Denghai Zhang
This network shows the impact of papers produced by Denghai Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denghai Zhang. The network helps show where Denghai Zhang may publish in the future.
Co-authors
The 25 scholars most cited alongside Denghai Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus Hit paper breakdown → | 2020 | 375 |
| 2 | 2019 | 221 | |
| 3 | 2010 | 140 | |
| 4 | 2010 | 92 | |
| 5 | 2019 | 84 | |
| 6 | 2012 | 79 | |
| 7 | 2006 | 55 | |
| 8 | 2015 | 37 | |
| 9 | 2009 | 37 | |
| 10 | 2010 | 27 | |
| 11 | 2018 | 27 | |
| 12 | 2015 | 26 | |
| 13 | 2016 | 22 | |
| 14 | 2014 | 18 | |
| 15 | 2018 | 18 | |
| 16 | 2013 | 14 | |
| 17 | 2017 | 11 | |
| 18 | 2016 | 10 | |
| 19 | 2017 | 10 | |
| 20 | 2022 | 10 |
About Denghai Zhang
Denghai Zhang is a scholar working on Complementary and alternative medicine, Molecular Biology, Cancer Research, Immunology and Oncology, having authored 36 papers that have together received 1.4k indexed citations. Recurring topics across this work include Natural Compounds in Disease Treatment (15 papers), Immunotherapy and Immune Responses (3 papers), MicroRNA in disease regulation (3 papers), Ferroptosis and cancer prognosis (2 papers), Heat shock proteins research (2 papers), Cell death mechanisms and regulation (2 papers), Circular RNAs in diseases (2 papers) and Neurological Disease Mechanisms and Treatments (2 papers). The work is most often cited by research in Complementary and alternative medicine (323 citations), Critical Care and Intensive Care Medicine (106 citations), Developmental Neuroscience (79 citations), Pharmacology (141 citations) and Cancer Research (185 citations). Denghai Zhang has collaborated with scholars based in China, France and United States. Frequent co-authors include Xue Zhang, Bin Peng, Yuting Song, Georges Uzan, Bin Peng, Fanfan Cao, Zhi‐Ru Ge, Shengqiong Deng, Hairong Wang and Xinghui Liu. Their work appears in journals such as Journal of Integrative Medicine, Molecular Cancer, International Immunopharmacology, BMC Cancer and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.